Characteristics | |
---|---|
Age (y) | 44 ± 16* |
Female gender n (%) | 15 (71) |
Functional capacity, n (%) | |
NYHA Functional Class I | 13 (61) |
NYHA Functional Class I-II | 8 (38) |
Drugs, n (%) | |
ACE inh. | 3 (14) |
Beta-Blocking agent | 3 (14) |
Mitral regurgitation follow-up n (%) | |
0-6 month | 3 (14) |
6 months-1 year | 3 (14) |
1 year< x < 3 years | 7 (33) |
3 year< x < 6 years | 2 (10) |
>6 years | 6 (29) |